Previous Close | 17.61 |
Open | 17.08 |
Bid | 16.00 x 800 |
Ask | 17.90 x 1200 |
Day's Range | 16.40 - 17.32 |
52 Week Range | 10.50 - 46.88 |
Volume | |
Avg. Volume | 1,043,224 |
Market Cap | 885.507M |
Beta (5Y Monthly) | 0.99 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.95 |
Earnings Date | Feb 22, 2023 - Feb 27, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 28.00 |
Let's not try to jinx things by calling attention to this, but Cathie Wood's on a roll this year. The largest of the exchange-traded funds she runs at Ark Investment Management is up nearly 23% this month. Wood added to her existing stakes in Pinterest (NYSE: PINS), CareDx (NASDAQ: CDNA), and Teladoc Health (NYSE: TDOC) yesterday.
CareDx, Inc ( NASDAQ:CDNA ) shareholders might be concerned after seeing the share price drop 24% in the last quarter...
BRISBANE, Calif., January 26, 2023--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Journal of the American College of Cardiology (JACC): Heart Failure has published a detailed guide1 to help clinicians transition from routine invasive endomyocardial biopsy (EMB) to a less invasive acute rejection monito